These findings improve our understanding of the mechanisms of pathogenesis of fetal macrosomia and will guide future development of therapeutic strategies against fetal macrosomia by targeting the circ-SETD2/miR-519a/PTEN axis. This evidence concerns the gene PTEN and Large for gestational age.